Strasbourg / Helsinki / London / Brussels / Abu Dhabi / /
Company
NEA 23andMe / The Wellcome Trust / Google / Ancestry.com / GlaxoSmithKline / In Vitro Diagnostics / UK Biobank / 23andMe / EC / lobbying by the Wellcome Trust / /
Continent
Europe / /
Country
Germany / United States / Canada / United Kingdom / /
Currency
EUR / / /
IndustryTerm
foreign security services / state law / health services / data protection law / data-mining / pharmaceutical / dual-use technology / draft law / evidence that its algorithms / http /
MedicalCondition
heart disease / disorder / breast cancer / Parkinson's / diabetes / diseases / /
Organization
Food and Drug Administration / Commission’s Justice Directorate / UK Government / European Parliament / European Parliament’s Civil Liberties / Justice and Home Affairs Committee / Civil society / UK Medical Research Council / US Federal Reserve / European Commission / LIBE Committee / Nuffield Foundation / European Council / European Union / Department of Health / Conservative Government / European Court of Human Rights / National Health Service / World Medical Association / retaining the NHS / /
Person
Juncker / Patrick Chung / George Freeman / / /
PoliticalEvent
Parliament vote / /
Position
board member / President / General Data Protection Regulation / researcher / data controller / Secretary of State / first draft General Data Protection Regulation / major driver of commercial interest / chair / Life Sciences Minister / controller / /
Data Protection or exploitation? The erosion of safeguards for health and genetic research May 2015